The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-11 of 11 articles
Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition
Gragnano F,
Spirito A,
Corpataux N,
Vaisnora L,
Galea R,
Gargiulo G,
Siontis G,
Praz F,
Lanz J,
Billinger M,
Hunziker L,
Stortecky S,
Pilgrim T,
Bär S,
Ueki Y,
Capodanno D,
Urban P,
Pocock S,
Mehran R,
Heg D,
Windecker S,
Räber L,
Valgimigli M
December 3, 2021 | 10.4244/EIJ-D-21-00181
Defining the HBR patient – another step in the right direction
August 28, 2020 | 10.4244/EIJV16I5A64
Polymer-free drug-coated stents: workhorse or “niche horse”?
September 20, 2018 | 10.4244/EIJV14I7A128
Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial
Lipiecki J,
Brunel P,
Morice M,
Roguelov C,
Walsh S,
Richardt G,
Eerdmans P,
Zambahari R,
Berland J,
Copt S,
Stoll H,
Urban P
July 20, 2018 | 10.4244/EIJ-D-18-00293
Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy
Jensen C,
Naber CK,
Urban P,
Ong P,
Valdés Chávarri M,
Abizaid A,
Pocock S,
Fabbiocchi F,
Dubois C,
Copt S,
Stoll H,
Morice M
March 20, 2018 | 10.4244/EIJ-D-17-00720
Polymer-free drug-coated coronary stents are cost-effective in patients at high bleeding risk: economic evaluation of the LEADERS FREE trial
Filipovic-Pierucci A,
Durand-Zaleski I,
Butel T,
Greene S,
Hovasse T,
Iñiguez A,
Nazzaro M,
Oldroyd K,
Talwar S,
Richardt G,
Windhovel U,
Urban P,
Morice M
February 20, 2018 | 10.4244/EIJ-D-17-00286
Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study
Danzi G,
Chevalier B,
Urban P,
Fath-Ordoubadi F,
Carrié D,
Wiemer M,
Serra A,
Wijns W,
Kala P,
Stabile A,
Ruigomez J,
Sagic D,
Laanmets P,
Strupp G,
West N,
Paunovic D
May 15, 2012 | 10.4244/EIJV8I1A17
Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry
Cuculi F,
Banning A,
Abizaid A,
Bartorelli AL,
Baux A,
Dzavik V,
Ellis S,
Gao R,
Holmes D,
Jeong MH,
Legrand V,
Neumann F,
Nyakern M,
Spaulding C,
Stoll H,
Worthley S,
Urban P
December 30, 2011 | 10.4244/EIJV7I8A152
Latest news
NEW ISSUE
The Bifurcation ARC consensus; impact of P2Y12 de-escalation in HBR; 5-year outcomes of the TARGET trial and more...
December 4, 2023
STATE-OF-THE-ART
Free access collection all year long
December 4, 2023
AHEAD OF PRINT
Poor improvement of post-PCI iFR in LAD
FREE ARTICLE - Mitsuaki Matsumura et al
November 30, 2023
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
PCR London Valves 2023
November 16, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023